Body Fat Distribution and Ectopic Fat Accumulation as Mediator of Diabetogenic Action of Lipid-Modifying Drugs: A

Yuanlong Hu1, Xinhai Cui2, Mengkai Lu3

  • 1First Clinical Medical College, Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China.

Mayo Clinic Proceedings
|February 7, 2025
PubMed
Abstract

Insights

Lipid-modifying drugs like HMGCR and APOB inhibitors increase type 2 diabetes risk, mediated by liver and gluteofemoral fat. LPL enhancers reduce risk, also mediated by these fat depots.

Area of Science:

  • Genetics and Pharmacology
  • Metabolic Diseases
  • Causal Inference

Background:

  • Lipid-modifying drugs are crucial for cardiovascular disease prevention.
  • The relationship between these drugs and new-onset diabetes requires further elucidation.
  • Ectopic fat accumulation is implicated in metabolic dysregulation.

Purpose of the Study:

  • To investigate the causal links between lipid-modifying drug targets and type 2 diabetes (T2D).
  • To identify mediating factors, specifically ectopic fat, in the drug-T2D association.
  • To differentiate prodiabetic and antidiabetic effects based on drug targets.

Main Methods:

  • Mediation Mendelian randomization analysis was employed.
  • Genetic variants for 11 lipid-modifying drug targets were analyzed.
  • Causal effects and mediation proportions were statistically evaluated.

Main Results:

  • HMGCR and APOB inhibition showed a causal association with increased T2D risk.
  • LPL enhancement demonstrated a causal association with reduced T2D risk.
  • Liver fat and gluteofemoral adipose tissue mediated these associations.

Conclusions:

  • Liver fat and gluteofemoral adipose tissue mediate the prodiabetic effects of HMGCR and APOB inhibition.
  • These fat depots also mediate the antidiabetic effects of LPL enhancement.
  • Findings highlight the role of fat accumulation in drug-induced diabetes risk.

Related Concept Videos

Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
959
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
497
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
366
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
10.7K
Drug Distribution: Tissue Binding01:21

Drug Distribution: Tissue Binding

Upon entering the systemic circulation, drugs can distribute into the interstitial and intracellular fluid of various tissue cells. This distribution is facilitated by the binding of drugs to different cellular components within tissues, which may lead to drug accumulation in specific areas. Drugs bound to tissue components serve as reservoirs that release free drugs back into the system, prolonging the drug's overall action. However, this accumulation can also result in local toxicity.
For...
2.5K
Factors Affecting Drug Distribution: Miscellaneous Factors01:19

Factors Affecting Drug Distribution: Miscellaneous Factors

Drug distribution in the human body is a complex process influenced by various individual factors, including age, pregnancy, obesity, diet, body water composition, pH levels, and specific disease conditions.
Age plays a significant role due to differences in body composition among different age groups. Infants, for instance, have a higher proportion of total body water and lower albumin levels, a protein that binds drugs in the bloodstream. This unique composition in infants enhances the...
247